GlassVC
No published image.

Robert Nelsen

Co-founder and Managing Director · ARCH Venture Partners

General PartnerSeattle, WA

Co-founder and Managing Director of ARCH Venture Partners, operating from Seattle. An initial investor in Illumina and co-founder of Juno Therapeutics and Denali Therapeutics; GeekWire notes two dozen of his companies have gone public over a thirty-year career.

Board seats

1411 current

· PUBLIC SOURCES

Credited hits

9

· PUBLIC SOURCES

Midas years

72025, 2021, 2019, 2018, 2017 +2 more

· FORBES

Founder rating

No public record

LAST CHECKED NOV 2026

Maintained from public sources. Not claimed. If you're Robert Nelsen, you can claim this profile.

Claim this profileHow claiming works

Claiming verifies identity and affiliation. It does not permit editing reviews, scores, or cited facts.

Track record

Credited deals only — Robert Nelsen is named in a public source as investor, lead, or board member on these deals. This is not a complete investment history, and absence here is not evidence of absence.
  • Illuminaipo

    Nelsen was an initial investor in Illumina per GeekWire's Midas profile; the company IPO'd in 2000.

    Source: geekwire.com

  • Juno Therapeuticsipo

    ARCH-backed cell-therapy company Nelsen co-founded; IPO'd in December 2014 at a $4B+ valuation per GeekWire.

    Source: geekwire.com

  • Karuna Therapeuticsacquired

    Acquired by Bristol-Myers Squibb, per ARCH bio.

    Source: archventure.com

  • Array BioPharmaacquired

    Acquired by Pfizer, per ARCH bio.

    Source: archventure.com

  • EQRxacquired

    Acquired by Revolution Medicines, per ARCH bio.

    Source: archventure.com

  • GRAILacquired

    Acquired by Illumina, per ARCH bio.

    Source: archventure.com

  • Receptosacquired

    Acquired by Celgene, per ARCH bio.

    Source: archventure.com

  • Verve Therapeuticsacquired

    Acquired by Eli Lilly, per ARCH bio.

    Source: archventure.com

  • Semma Therapeuticsacquired

    Acquired by Vertex Pharmaceuticals, per ARCH bio.

    Source: archventure.com

Board seats

Current board seats · 11

Former board seats · 3

Success signals

Forbes Midas List

2025 · 2021 · 2019 · 2018 · 2017 · 2016 · 2008

On the Forbes Midas List in 7 years.

Reputation

No reputation score — basis not established for this investor.

Contact

Published sources only

Published contact details collected from public sources. Not a referral, and not an introduction.

Published contact

Published sources only

GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.

Claimed profiles can replace or remove contact details.

What founders say

Founder-submitted · Verified identity and relationship

No founder reviews yet

Be the first founder to share your experience with Robert Nelsen. Reviews come from founders whose identity and relationship have been verified.

Write the first review
Reviews of ARCH Venture Partners (0) →

Firm-level reviews are not attributed to Robert Nelsen.

Methodology

This profile carries no tier: tier belongs to the firm and is shown only via the linked firm name — never inherited onto a person.

Credited deals, board seats, Midas years and reputation links are carried per investor in the catalog, each item with the public source it was credited from, linked from the sections above. Fields with no sourced record render their honest null states, and every published field traces to the catalog record listed below. Review dimension scores appear only at three or more reviews.

Corrections with a source: Suggest a correction.

Source record 1

  1. [1]

    DATABASE · GlassVC catalog — Catalog record for Robert Nelsen — provenance: GlassVC extended catalog, November 2026

    CATALOG SOURCE FIELD · LAST CHECKED NOV 2026

    ↩ cites: Title · Firm · Type · Bio · Location · Focus · Credited deals · Board seats · Midas years · Reputation

EVERY FIGURE ON THIS PAGE IS TRACEABLE TO THE CATALOG RECORD ABOVE · LAST CHECKED NOV 2026